This is consistent with observations in Siglec G−/− bone marrow chimeras, where the lack of inhibitory signaling by Siglec G led to increased OSE-specific natural IgM antibody levels and decreased atherosclerosis development (24). The gene discussed is CD40LG; the disease is atherosclerosis.